Healthcare
Hospital Network Patient Outcome Data
12 years of longitudinal patient outcomes across 6 therapeutic areas. 250,000 patients. A DataVault assessment revealed pharma R&D and real-world evidence opportunities worth millions annually.
The Asset
Treatment protocols, outcome measurements, adverse events, demographic data, and diagnostic codes. The network's Chief Medical Officer recognised the research value but had no commercial framework to act on it.
Five-Lens Valuation
Each lens independently assesses the asset's commercial worth
Top 3 Monetization Pathways
Ranked by revenue potential for this specific asset
Pharma R&D Licensing
€10M–25M one-timeExclusive training rights for drug discovery AI models. Pseudonymised cohort with treatment-outcome labels.
Real-World Evidence DaaS
€3M–5M annualSubscription access for health economics and outcomes research (HEOR) teams at 3-5 pharma companies.
Clinical Benchmark Index
€600K–1M annualAnonymised treatment efficacy benchmarks licensed to insurance actuaries and health policy institutes.
What Could Your Healthcare Data Be Worth?
Patient outcome data is among the highest-value assets in the marketplace. Start with a free 30-minute scoping call — no preparation needed.
Get Started with DE platform
Helping organisations discover, value and commercialize their data assets through evidence-based DataVault assessments and an AI-driven marketplace. Your data stays in your environment. We earn when you earn.
Services
Company